Topic: Forest Laboratories Inc.

Forest Laboratories (NYSE: FRX)'s stock had its "buy" rating reiterated by research analysts at Cantor Fitzgerald in a report issued on Wednesday...
Forest Laboratories (NYSE: FRX)'s stock had its "neutral" rating reaffirmed by Zacks Investment Research in a research report issued to clients and...
Shares of Forest Laboratories, Inc. (FRX) hit a new 52-week low on Wednesday. The stock traded as low as $28.48 during mid-day trading and last...
Equities research analysts at Barclays Capital (NYSE: BCS) initiated coverage on shares of Forest Laboratories (NYSE: FRX) in a research note...
Forest Laboratories, Inc. (NYSE: FRX) is a pharmaceutical company that specializes in therapeutics for the central nervous and cardiovascular...
Posted on 10/24/11 at 6:23am by Eddie Staley . Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) and Forest Laboratories, Inc. (NYSE: FRX ) today...
Posted on 10/19/11 at 9:55am by Joe Young . Jefferies & Company has published a research report on Forest Laboratories (NYSE: FRX ) and has lowered...
Posted on 10/19/11 at 7:40am by Joe Young . Deutsche Bank has lowered the price target on Forest Laboratories (NYSE: FRX ) from $34 to $33 and...

Forest Labs Posts Weak Quarter

Forest Laboratories(FRX) posted a lower-than-expected quarterly profit on disappointing drug sales and higher costs. Despite the weak quarter...

Forest Laboratories' Net Income Shrinks

Posted on 10/18/11 at 9:33am by Benzinga Staff Writer . Forest Laboratories (NYSE: FRX ) announced its results for the second quarter on October...